Studies of the Early Bactericidal Activity of New Drugs for Tuberculosis
- 1 July 2002
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 166 (1) , 3-4
- https://doi.org/10.1164/rccm.2205007
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- A Reiterative Method for Calculating the Early Bactericidal Activity of Antituberculosis DrugsAmerican Journal of Respiratory and Critical Care Medicine, 2002
- A Prospective, Randomized, Double-Blind Study of the Tolerability of Rifapentine 600, 900, and 1,200 mg Plus Isoniazid in the Continuation Phase of Tuberculosis TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosisBMC Pulmonary Medicine, 2001
- Safety and Bactericidal Activity of Rifalazil in Patients with Pulmonary TuberculosisAntimicrobial Agents and Chemotherapy, 2001
- The Need for New Drugs against TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Foreword from the Co-Editor-in-ChiefTuberculosis, 2001
- A multicentre study of the early bactericidal activity of anti-tuberculosis drugs.Journal of Antimicrobial Chemotherapy, 2000
- Measurement of Sputum Mycobacterium tuberculosis Messenger RNA as a Surrogate for Response to ChemotherapyAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Early Bactericidal Activity of Isoniazid in Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 1997
- The Early Bactericidal Activity of Isoniazid Related to Its Dose Size in Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 1997